Literature DB >> 2890980

Screening test for ataxia telangiectasia.

D Schindler, H Seyschab, M Poot, H Hoehn, A Schinzel, J P Fryns, N Tommerup, P S Rabinovitch.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2890980     DOI： 10.1016/s0140-6736(87)91288-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Use of the glycophorin A somatic mutation assay for rapid, unambiguous identification of Fanconi anemia homozygotes regardless of GPA genotype.

Authors:  Viktoria N Evdokimova; Reagan K McLoughlin; Sharon L Wenger; Stephen G Grant
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

2.  Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany.

Authors:  Christina M Dutzmann; Claudia Spix; Isabell Popp; Melanie Kaiser; Friederike Erdmann; Miriam Erlacher; Thilo Dörk; Detlev Schindler; Reinhard Kalb; Christian P Kratz
Journal:  J Clin Oncol       Date:  2021-10-01       Impact factor: 44.544

3.  Simultaneous measurement, using flow cytometry, of radiosensitivity and defective mitogen response in ataxia telangiectasia and related syndromes.

Authors:  H Seyschab; D Schindler; R Friedl; G Barbi; E Boltshauser; J P Fryns; F Hanefeld; R Korinthenberg; I Krägeloh-Mann; J M Scheres
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

Review 4.  Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective.

Authors:  J P Murnane
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

5.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.